Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Prolactinoma 5Pituitary Neoplasms 4Polycystic Ovary Syndrome 3Hyperprolactinemia 2Recurrence 1Prolactin Deficiency, Isolated 1Pituitary ACTH Hypersecretion 1Ovarian Hyperstimulation Syndrome 1Heart Valve Diseases 1Breast Neoplasms 1Adenoma 1ACTH-Secreting Pituitary Adenoma 1

Interventions

fimepinostat 1Rosiglitazone 1Perceived Stress Scale 1Magnetic Resonance Spectroscopy 1Cabergoline 1Biomarkers 14-amino-4'-hydroxylaminodiphenylsulfone 12-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pituitary ACTH Hypersecretion × Cabergoline × Clear all
NCT00889525 2009-04-29

Study of Cabergoline in Treatment of Corticotroph Pituitary Tumor

Seth Gordhandas Sunderdas Medical College

Phase 3 Completed
Endocrine

Pituitary ACTH Hypersecretion, ACTH-Secreting Pituitary Adenoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡